InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

KP

Kim Paul

Chief Financial Officer

CFOF

Fulgent Genetics, Inc.

Cumul. flow

0

Total declarations

0

Company

€2m

▲ Purchases (1 ops.)

€3m

▼ Sales (24 ops.)

Insider track record

CFO

Disclosed buys

1

Disclosed sells

24

T+90 hit rate

100%

T+90 mean return

+17.6%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the complete record of transactions filed by Kim Paul, Chief Financial Officer. Insider active across 1 company, notably Fulgent Genetics, Inc.. Aggregated, 80 filings have been published. Breakdown: 1 buy · 24 sells. Total volume traded: €4.2m. History available since 18 May 2021. The latest transaction was filed on 26 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Kim Paul

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Fulgent Genetics, Inc. (US)

Declarations80 total

●

CFO and TreasurerExecutives26 Aug 2026Fulgent Genetics, Inc.

$23,1380SEC ↗

1,168 shares@ US$19.81Common StockSEC:0001253820-26-000009:0

●

CFO and TreasurerExecutives26 Jul 2026Fulgent Genetics, Inc.

$54,03324SEC ↗

2,747 shares@ US$19.670.0097% mcap1.4% of flowCommon StockSEC:0001193125-26-321087:0

●

CFO and TreasurerExecutives26 May 2026Fulgent Genetics, Inc.

$20,63923SEC ↗

1,168 shares@ US$17.670.0034% mcap0.6% of flowCommon StockSEC:0001253820-26-000003:0

●

CFO and TreasurerExecutives26 Apr 2026Fulgent Genetics, Inc.

$44,80427SEC ↗

2,747 shares@ US$16.310.0074% mcap1.2% of flowCommon StockSEC:0001193125-26-187445:0

●

CFO and TreasurerExecutives26 Feb 2026Fulgent Genetics, Inc.

$28,92031SEC ↗

1,168 shares@ US$24.760.0055% mcap50.0% of flowCommon StockSEC:0001253820-26-000001:0

●

CFO and TreasurerExecutives23 Feb 2026Fulgent Genetics, Inc.

$15,21024SEC ↗

661 shares@ US$23.010.4% of flowCommon StockSEC:0001193125-26-072641:0

●

CFO and TreasurerExecutives26 Jan 2026Fulgent Genetics, Inc.

$82,70024SEC ↗

3,004 shares@ US$27.532.1% of flowCommon StockSEC:0001193125-26-027397:0

●

CFO and TreasurerExecutives1 Dec 2025Fulgent Genetics, Inc.

$32,25624SEC ↗

1,131 shares@ US$28.520.8% of flowCommon StockSEC:0001193125-25-306924:0

●

CFO and TreasurerExecutives26 Nov 2025Fulgent Genetics, Inc.

$35,15524SEC ↗

1,166 shares@ US$30.150.9% of flowCommon StockSEC:0001193125-25-304201:0

●

CFO and TreasurerExecutives23 Nov 2025Fulgent Genetics, Inc.

$20,13024SEC ↗

671 shares@ US$30.000.5% of flowCommon StockSEC:0001193125-25-297326:0

●

CFO and TreasurerExecutives26 Oct 2025Fulgent Genetics, Inc.

$65,11924SEC ↗

2,743 shares@ US$23.741.7% of flowCommon StockSEC:0001193125-25-253872:0

●

CFO and TreasurerExecutives1 Sept 2025Fulgent Genetics, Inc.

$25,07424SEC ↗

1,131 shares@ US$22.170.7% of flowCommon StockSEC:0001253820-25-000008:0

●

CFO and TreasurerExecutives26 Aug 2025Fulgent Genetics, Inc.

$25,03424SEC ↗

1,166 shares@ US$21.470.7% of flowCommon StockSEC:0001253820-25-000006:0

●

CFO and TreasurerExecutives23 Aug 2025Fulgent Genetics, Inc.

$14,58624SEC ↗

670 shares@ US$21.770.4% of flowCommon StockSEC:0001253820-25-000004:0

●

CFO and TreasurerExecutives26 Jul 2025Fulgent Genetics, Inc.

$50,38924SEC ↗

2,743 shares@ US$18.371.4% of flowCommon StockSEC:0000950170-25-099793:0

●

CFO and TreasurerExecutives1 Jun 2025Fulgent Genetics, Inc.

$23,43425SEC ↗

1,131 shares@ US$20.720.7% of flowCommon StockSEC:0000950170-25-081053:0

●

CFO and TreasurerExecutives23 May 2025Fulgent Genetics, Inc.

$13,62825SEC ↗

671 shares@ US$20.310.4% of flowCommon StockSEC:0000950170-25-078348:0

●

CFO and TreasurerExecutives26 May 2025Fulgent Genetics, Inc.

$23,68121SEC ↗

1,166 shares@ US$20.310.6% of flowCommon StockSEC:0000950170-25-078348:1

●

CFO and TreasurerExecutives26 Apr 2025Fulgent Genetics, Inc.

$51,78825SEC ↗

2,743 shares@ US$18.881.5% of flowCommon StockSEC:0000950170-25-060280:0

▲

CFO and TreasurerExecutives5 Mar 2025Fulgent Genetics, Inc.

100,000 shares@ US$15.964749.4% of flowCommon StockSEC:0000950170-25-033994:0

Canonical exit: 3 Jun 2025 (T+90)

●

CFO and TreasurerExecutives1 Mar 2025Fulgent Genetics, Inc.

$24,04019SEC ↗

1,556 shares@ US$15.450.8% of flowCommon StockSEC:0000950170-25-032775:0

◆

CFO and TreasurerExecutives25 Feb 2025Fulgent Genetics, Inc.

3,384 shares0Common StockSEC:0000950170-25-029436:0

●

CFO and TreasurerExecutives23 Feb 2025Fulgent Genetics, Inc.

$12,06519SEC ↗

733 shares@ US$16.460.4% of flowCommon StockSEC:0000950170-25-026883:0

●

CFO and TreasurerExecutives26 Jan 2025Fulgent Genetics, Inc.

$51,63019SEC ↗

3,000 shares@ US$17.211.6% of flowCommon StockSEC:0000950170-25-009842:0

●

CFO and TreasurerExecutives1 Dec 2024Fulgent Genetics, Inc.

$28,42019SEC ↗

1,553 shares@ US$18.300.9% of flowCommon StockSEC:0000950170-24-133315:0

25 of 80 declarations

About Kim Paul

Kim Paul is Directeur Financier at Fulgent Genetics, Inc. (XNAS), where he also serves as CFO and Treasurer. The declarant has 76 filings in total, and among the recent filings tracked here, buys amount to EUR 1502278 and sells to EUR 2668198, between 2021-05-20 and 2026-05-28, with tax withholding as the most frequent transaction nature.